Cas:91940-87-3 Zatebradine (hydrochloride) manufacturer & supplier

We serve Chemical Name:Zatebradine (hydrochloride) CAS:91940-87-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Zatebradine (hydrochloride)

Chemical Name:Zatebradine (hydrochloride)
CAS.NO:91940-87-3
Synonyms:Zatebradine dihydrochloride;Zatebradine hydrochloride;UL-FS49;Zatebradine (hydrochloride)
Molecular Formula:C26H37ClN2O5
Molecular Weight:493.03500
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:612.5ºC at 760mmHg
Density:1.115g/cm3
Index of Refraction:
PSA:60.47000
Exact Mass:492.23900
LogP:3.95270

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like Zatebradine dihydrochloride chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Zatebradine (hydrochloride) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,UL-FS49 Use and application,Zatebradine (hydrochloride) technical grade,usp/ep/jp grade.


Related News: When they do design their phase 3, they’re going to need to be better about that part of the study design, and really focus on enrolling individuals that have the right biomarkers to be able to look at not only the safety and tolerability but also the efficacy on cognition and function,” Edelmayer said.
The vaccine approach is promising because using the body’s immune system to fight Alzheimer’s would sidestep one of the problems in developing a drug to treat the disease — namely that it’s difficult to design medications that can easily enter the brain and attack a specific target, Edelmayer explained.
Through booster doses given every three months, the vaccine is “training your body over time how to react to the pathological tau,” Edelmayer said. “You will likely need additional shots of this particular therapeutic to keep it as productive as possible in targeting that tau. Zatebradine (hydrochloride) manufacturer Dr. John K. Westwick, CEO of Resonant, added ��Resonant has created a platform for rapid generation of novel anti-tumor antibody candidates. Zatebradine (hydrochloride) supplier With the speeding up of review and approval, the number of approved innovative drugs in China is about to usher in a year of blowout. Zatebradine (hydrochloride) vendor Dr. John K. Westwick, CEO of Resonant, added ��Resonant has created a platform for rapid generation of novel anti-tumor antibody candidates. Zatebradine (hydrochloride) factory Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country.